Cagrilintide/Semaglutide 2.4/2.4 or 5/5

Sale!

Cagrilintide/Semaglutide 2.4/2.4 or 5/5

Price range: $74.99 through $129.99

2.4/2.4 mg & 5/5 mg

FREE & FAST SHIPPING

PUREST QUALITY

EXCELLENT SERVICE

Properties

Molecular Formula
Molecular Weight
Monoisotopic Mass
Polar Area
Complexity
XLogP
Heavy Atom Count
Hydrogen Bond Donor Count
Hydrogen Bond Acceptor Count
Rotatable Bond Count
Physical Appearance
Stability
PubChem LCSS

Identifiers

CID
CAS
InChI
InChIKey
Isomeric SMILES
Canonical SMILES
IUPAC Name

Description

Cagrilintide/Semaglutide

Product is sold for prescriber purposes only. Please handle with care and follow all safety guidelines for the specific chemicals involved.

Combining cagrilintide/semaglutide in rat models offers a promising approach to studying obesity and metabolic disorders. Cagrilintide, an amylin receptor agonist, and semaglutide, a GLP-1 receptor agonist, have individually demonstrated efficacy in reducing body weight and improving insulin sensitivity. When administered together, they may provide synergistic effects, enhancing therapeutic outcomes.

Mechanisms of Action

Cagrilintide acts by binding to amylin receptors, leading to reduced food intake and increased satiety. Semaglutide, on the other hand, enhances insulin secretion and inhibits glucagon release, contributing to improved glucose homeostasis. In rat studies, cagrilintide has been shown to lower body weight through activation of brain amylin receptors 1 and 3. Semaglutide’s effects on body weight and glucose regulation have been well-documented in rodent models.

Preclinical Evidence

In a study involving Zucker Diabetic Sprague Dawley (ZDSD) rats, the combination of cagrilintide/semaglutide led to significant reductions in body weight and improved glucose control compared to vehicle-treated rats. Another investigation found that cagrilintide/semaglutide, when administered together, resulted in superior weight loss outcomes in diet-induced obese rats.

Clinical Implications

The promising results observed in rat models have translated into human studies. In the REDEFINE 1 clinical trial, the combination of cagrilintide/semaglutide demonstrated superior weight loss compared to either agent alone . These findings suggest that the combination therapy may offer enhanced efficacy in managing obesity and related metabolic conditions.

Conclusion

Utilizing rat models to investigate the combined effects of cagrilintide/semaglutide provides valuable insights into their potential synergistic benefits. The preclinical evidence supports further exploration of this combination therapy as a promising approach to treating obesity and metabolic disorders.

References

ALL LITERATURE, INFORMATION, AND DATA, PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

Tirz 10mg

Accurate research is our number one priority.

Same Day Shipping

Enjoy the convenience of receiving your order swiftly. We offer same-day shipping on all orders of in-stock items placed before 12:00 pm EST.

Dedicated Service

Our dedicated team is always at your service, Ready to assist you with any customer service requests you may have. We prioritize your satisfaction and aim to provide a seamless experience.

Free Shipping

To enhance your shopping experience, We offer free shipping on all orders totaling $200 or more. Rest assured, we've got you covered!

Purist Quality

We take pride in ensuring the utmost purity of our products. Every item we offer undergoes rigorous lab testing and is certified for the highest possible purity.

Shopping cart

0
image/svg+xml

No products in the cart.

Continue Shopping